209 related articles for article (PubMed ID: 25114133)
1. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors.
Vargiu AV; Ruggerone P; Opperman TJ; Nguyen ST; Nikaido H
Antimicrob Agents Chemother; 2014 Oct; 58(10):6224-34. PubMed ID: 25114133
[TBL] [Abstract][Full Text] [Related]
2. Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of
Atzori A; Malloci G; Cardamone F; Bosin A; Vargiu AV; Ruggerone P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013182
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into the determinants of substrate specificity and efflux inhibition of the RND efflux pumps AcrB and AdeB.
Wilhelm J; Pos KM
Microbiology (Reading); 2024 Feb; 170(2):. PubMed ID: 38358391
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study.
Rathod S; Dey S; Pawar S; Dhavale R; Choudhari P; Rajakumara E; Mahuli D; Bhagwat D; Tamboli Y; Sankpal P; Mali S; More H
J Biomol Struct Dyn; 2024 Jul; 42(10):5178-5196. PubMed ID: 37340697
[TBL] [Abstract][Full Text] [Related]
5. Molecular Interactions of Cephalosporins with the Deep Binding Pocket of the RND Transporter AcrB.
Atzori A; Malloci G; Prajapati JD; Basciu A; Bosin A; Kleinekathöfer U; Dreier J; Vargiu AV; Ruggerone P
J Phys Chem B; 2019 Jun; 123(22):4625-4635. PubMed ID: 31070373
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the molecular and functional basis of TMexCD1: the plasmid-encoded efflux pump of resistance-nodulation-division superfamily.
Shang Y; Zhang Y; Wang R; Peng Y; Ding B; Liu Y; Li C; Feng L; Liu H; Yang C; Tang Y
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0167823. PubMed ID: 38477539
[TBL] [Abstract][Full Text] [Related]
7. Pyrrole-based inhibitors of RND-type efflux pumps reverse antibiotic resistance and display anti-virulence potential.
Mahey N; Tambat R; Kalia R; Ingavale R; Kodesia A; Chandal N; Kapoor S; Verma DK; Thakur KG; Jachak S; Nandanwar H
PLoS Pathog; 2024 Apr; 20(4):e1012121. PubMed ID: 38593161
[TBL] [Abstract][Full Text] [Related]
8. Significant Impact of AcrB Amino Acid Polymorphism at Residue 716 on Susceptibility to Tigecycline and Other Antibiotics in
Wang W; Ma Y; Ma Y; Zheng X; Yu J; Li L; Liu X; Gao H; Xu H; Wang M
ACS Infect Dis; 2024 Feb; 10(2):541-552. PubMed ID: 38181222
[TBL] [Abstract][Full Text] [Related]
9. The challenge of intracellular antibiotic accumulation, a function of fluoroquinolone influx versus bacterial efflux.
Vergalli J; Atzori A; Pajovic J; Dumont E; Malloci G; Masi M; Vargiu AV; Winterhalter M; Réfrégiers M; Ruggerone P; Pagès JM
Commun Biol; 2020 Apr; 3(1):198. PubMed ID: 32346058
[TBL] [Abstract][Full Text] [Related]
10. Machine Learning-Guided Discovery of AcrB and MexB Efflux Pump Inhibitors.
Bera A; Roy RK; Joshi P; Patra N
J Phys Chem B; 2024 Jan; 128(3):648-663. PubMed ID: 38198225
[TBL] [Abstract][Full Text] [Related]
11. High-throughput computational screening for identification of potential hits against bacterial Acriflavine resistance protein B (AcrB) efflux pump.
Rathod S; Dey S; Choudhari P; Mahuli D; Rochlani S; Dhavale R; Chaudhari S; Tamboli Y; Kilbile J; Rajakumara E
J Biomol Struct Dyn; 2024 Jan; ():1-17. PubMed ID: 38264919
[TBL] [Abstract][Full Text] [Related]
12. There is a baby in the bath water: AcrB contamination is a major problem in membrane-protein crystallization.
Veesler D; Blangy S; Cambillau C; Sciara G
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Oct; 64(Pt 10):880-5. PubMed ID: 18931428
[TBL] [Abstract][Full Text] [Related]
13. Development of pharmacophore models for AcrB protein and the identification of potential adjuvant candidates for overcoming efflux-mediated colistin resistance.
Behera DU; Gaur M; Sahoo M; Subudhi E; Subudhi BB
RSC Med Chem; 2024 Jan; 15(1):127-138. PubMed ID: 38283226
[TBL] [Abstract][Full Text] [Related]
14. Functionally distinct mutations within AcrB underpin antibiotic resistance in different lifestyles.
Trampari E; Prischi F; Vargiu AV; Abi-Assaf J; Bavro VN; Webber MA
NPJ Antimicrob Resist; 2023; 1(1):2. PubMed ID: 38686215
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
[TBL] [Abstract][Full Text] [Related]
16. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.
Nguyen ST; Kwasny SM; Ding X; Cardinale SC; McCarthy CT; Kim HS; Nikaido H; Peet NP; Williams JD; Bowlin TL; Opperman TJ
Bioorg Med Chem; 2015 May; 23(9):2024-34. PubMed ID: 25818767
[TBL] [Abstract][Full Text] [Related]
18. Recent advances toward a molecular mechanism of efflux pump inhibition.
Opperman TJ; Nguyen ST
Front Microbiol; 2015; 6():421. PubMed ID: 25999939
[TBL] [Abstract][Full Text] [Related]
19. Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump AcrB.
Eicher T; Seeger MA; Anselmi C; Zhou W; Brandstätter L; Verrey F; Diederichs K; Faraldo-Gómez JD; Pos KM
Elife; 2014 Sep; 3():. PubMed ID: 25248080
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Pseudomonas aeruginosa LpxC with its inhibitors in an acrB-deficient Escherichia coli strain.
Gao N; McLeod SM; Hajec L; Olivier NB; Lahiri SD; Bryan Prince D; Thresher J; Ross PL; Whiteaker JD; Doig P; Li AH; Hill PJ; Cornebise M; Reck F; Hale MR
Protein Expr Purif; 2014 Dec; 104():57-64. PubMed ID: 25240855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]